Skip to main content Back to Top

ISMP Targeted Medication Safety Best Practices for Hospitals #7 - neuromuscular blocking agents (NMB)

Broadcast Date: January 12, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.


Jennifer HowardJennifer Howard, Pharm.D., is the Director of Medication Safety at the VA San Diego Healthcare System. Dr. Howard received her Pharm.D. degree from the University of the Pacific School of Pharmacy in Stockton, California. She completed a Pharmacy Practice Residency with a Geriatric Emphasis at the VA San Diego Healthcare System. She has also served in numerous roles at VA San Diego including Inpatient Clinical Pharmacist, Associate Director of Inpatient Pharmacy Services and Director of Pharmacy Informatics.

Joel DanielJoel W Daniel, Pharm.D., M.S., CPPS serves as System Medication Safety Pharmacist for CoxHealth in southwest Missouri. CoxHealth consists of six hospitals with associated regional clinics and surgical centers. Dr. Daniel’s primary work focuses on protecting patients and staff from complexity in healthcare by streamlining quality improvement within medication management (examples: system-wide anaphylaxis protocols, leading and maintaining a 50% reduction in opioid harms, and addressing alert fatigue).


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.